TY  - RPRT
TI  - Population Pharmacokinetics of an Anti-PD-1 Antibody Camrelizumab in Patients with Multiple tumor types and model informed dosing strategy
AU  - Wang, C.
AU  - Sheng, C.
AU  - Ma, G.
AU  - Xu, D.
AU  - Liu, X.
AU  - Wang, Y.
AU  - Zhang, L.
AU  - Cui, C.
AU  - Xu, B.
AU  - Song, Y.
AU  - Zhu, J.
AU  - Jiao, Z.
PY  - 2020
DO  - 10.1101/2020.06.30.180117
UR  - https://www.biorxiv.org/content/10.1101/2020.06.30.180117v1
ID  - 10.1101/2020.06.30.180117
ER  -